Bipolar disorder

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by EverSince (talk | contribs) at 16:10, 23 September 2008 (add link to ref, move from epi to treatment that it's focused on). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bipolar disorder
SpecialtyPsychiatry, clinical psychology Edit this on Wikidata

Bipolar disorder is a psychiatric diagnosis that describes a category of mood disorders defined by the presence of one or more episodes of abnormally elevated mood clinically referred to as mania or, if milder, hypomania. Individuals who experience manic episodes also commonly experience depressive episodes or symptoms, or mixed episodes in which features of both mania and depression are present at the same time. These episodes are usually separated by periods of "normal" mood, but in some individuals, depression and mania may rapidly alternate, known as rapid cycling. Extreme manic episodes can sometimes lead to psychotic symptoms such as delusions and hallucinations. The disorder has been subdivided into bipolar I, bipolar II, Bipolar Not Otherwise Specified and cyclothymia, based on the type and severity of mood episodes experienced; this range is often described as a bipolar spectrum.

Data from the United States indicates a lifetime prevalence rate of 0.8% for Bipolar I, 0.5% for Bipolar II/cyclothymia, and 5.1% for subthreshold cases meeting some but not all criteria. The onset of symptoms generally occurs in young adulthood. Diagnosis is based on the person's self-reported experiences, as well as observed behavior. Episodes of abnormality are associated with distress and disruption, and an elevated risk of suicide, especially during depressive episodes. In some cases it can be a devastating long-lasting disorder. Some subtypes, however, have also been associated with creativity, goal striving and positive achievements. Depending on the jurisdiction, in serious cases in which there is a risk of harm to oneself or others involuntary commitment may be used; these cases generally involve severe manic episodes with dangerous behaviour or depressive episodes with suicidal ideation. There are widespread problems with social stigma, stereotypes and prejudice regarding individuals with a diagnosis of bipolar disorder.

Studies suggest that genetics, early environment, neurobiology, and psychological and social processes are important contributory factors. Psychiatric research is focused on the role of neurobiology, but a clear organic cause has not been found. Bipolar disorder is usually treated with medications and/or counseling. The mainstay of medication is a number of drugs termed 'mood stabilizers', in particular lithium and sodium valproate; these are chemically unrelated medications used to prevent relapses of further episodes. Antipsychotic medications, sometimes called neuroleptics, in particular olanzapine, are used to treat and prevent manic episodes. The benefits of using antidepressants in depressive episodes is unclear.

Also called manic depression or bipolar affective disorder, the current term is of fairly recent origin and refers to the cycling between high and low episodes (poles). A relationship between mania and melancholia had long been observed, although the basis of the current conceptualisation can be traced back to French psychiatrists in the 1850s. The term "manic-depressive illness" or psychosis was coined by German psychiatrist Emil Kraepelin (1856–1926) in the late nineteenth century, originally referring to all kinds of mood disorder. German psychiatrist Karl Leonhard split the classification again in 1957, employing the terms unipolar disorder (Major depressive disorder) and bipolar disorder.

Signs and symptoms

Bipolar disorder is a condition in which people experience abnormally elevated (manic or hypomanic) and abnormally depressed states for significant periods of time, in a way that interferes with functioning.

Major depressive episode

Signs and symptoms of the depressive phase of bipolar disorder include: persistent feelings of sadness, anxiety, guilt, anger, isolation and/or hopelessness, disturbances in sleep and appetite, fatigue and loss of interest in usually enjoyed activities, problems concentrating, loneliness, self-loathing, apathy or indifference, depersonalization, loss of interest in sexual activity, shyness or social anxiety, irritability, chronic pain (with or without a known cause), lack of motivation, and morbid/suicidal ideation.[1] In severe cases, the individual may become psychotic, a condition also known as severe bipolar depression with psychotic features.

Manic episode

Mania is generally characterized by a distinct period of an elevated, expansive, or irritable mood state. People commonly experience an increase in energy and a decreased need for sleep. A person's speech may be pressured, with thoughts experienced as racing. Attention span is low and a person in a manic state may be easily distracted. Judgment may become impaired; sufferers may go on spending sprees or engage in behavior that is quite abnormal for them. They may indulge in substance abuse, particularly alcohol or other depressants, cocaine or other stimulants, or sleeping pills. Their behavior may become aggressive or intrusive. People may feel they have been "chosen", are "on a special mission", or other grandiose or delusional ideas. Sexual drive may increase. At more extreme phases, a person in a manic state can begin to experience psychosis, or a break with reality, where thinking is affected along with mood.[2] Many people in a manic state experience severe anxiety and are very irritable (to the point of rage), while others are euphoric and grandiose.

In order to be diagnosed with mania according to DSM-IV a person must experience this state of elevated or irritable mood, as well as other symptoms, for at least one week, less if hospitalisation is required. According to the National Institute of Mental Health, "A manic episode is diagnosed if elevated mood occurs with three or more of the other symptoms most of the day, nearly every day, for 1 week or longer. If the mood is irritable, four additional symptoms must be present."[3]

Hypomanic episode

Hypomania is generally a less extreme state than mania, and people in the hypomanic phase generally experience fewer symptoms of mania than those in a full-blown manic episode. During an episode, one might feel an uncontrollable impulse to laugh at things he or she does not normally find funny.[citation needed] The duration is usually also shorter than in mania. This is often a very "artistic" state of the disorder, in which a flight of ideas, extremely clever thinking, and an increase in energy can occur.

Mixed affective episode

In the context of bipolar disorder, a mixed state is a condition during which symptoms of mania and clinical depression occur simultaneously (for example, agitation, anxiety, aggressiveness or belligerence, confusion, fatigue, impulsiveness, insomnia, irritability, morbid and/or suicidal ideation, panic, paranoia, persecutory delusions, pressured speech, racing thoughts, restlessness, and rage).[4]

Diagnosis

Diagnosis is based on the self-reported experiences of an individual as well as abnormalities in behavior reported by family members, friends or co-workers, followed by secondary signs observed by a psychiatrist, nurse, social worker, clinical psychologist or other clinician in a clinical assessment. There are lists of criteria for someone to be so diagnosed. These depend on both the presence and duration of certain signs and symptoms. Assessment is usually done on an outpatient basis; admission to an inpatient facility is considered if there is a risk to oneself or others. The most widely used criteria for diagnosing bipolar disorder are from the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, the current version being DSM-IV-TR, and the World Health Organization's International Statistical Classification of Diseases and Related Health Problems, currently the ICD-10. The latter criteria are typically used in Europe and other regions while the DSM criteria are used in the USA and other regions, as well as prevailing in research studies.

An initial assessment may include a physical examination by a physician. Although there are no biological tests which confirm bipolar disorder, tests may be carried out to exclude medical illnesses such as hypo- or hyperthyroidism, metabolic disturbance, a systemic infection or chronic disease, and syphilis or HIV infection. An EEG may be used to exclude epilepsy, and a CT scan of the head to exclude brain lesions. Investigations are not generally repeated for relapse unless there is a specific medical indication.

There are several other mental disorders which may involve similar symptoms to bipolar disorder. These include schizophrenia,[5], schizoaffective disorder, drug intoxication, brief drug-induced psychosis, schizophreniform disorder and borderline personality disorder. Both borderline personality and bipolar disorder can involve what are referred to as "mood swings". In bipolar disorder, the term refers to the cyclic episodes of elevated and depressed mood which generally last weeks or months. The term in borderline personality refers to the marked lability and reactivity of mood, known as emotional dysregulation, due to response to external psychosocial and intrapsychic stressors; these may arise or subside suddenly and dramatically and last for seconds, minutes, hours or days. A bipolar depression is generally more pervasive with sleep, appetite disturbance and nonreactive mood, whereas the mood in dysthymia of borderline personality remains markedly reactive and sleep disturbance not acute.[6] Some hold that borderline presonality disorder represents a subthreshold form of mood disorder,[7][8] while others maintain the distinctness, though noting they often coexist.[9][10]

Criteria and subtypes

There is no clear consensus as to how many types of bipolar disorder exist.[11] In DSM-IV-TR and ICD-10, bipolar disorder is conceptualized as a spectrum of disorders occurring on a continuum. The DSM-IV-TR lists four types of mood disorders which fit into the bipolar categories: Bipolar I, Bipolar II, Cyclothymia, and Bipolar Disorder NOS (Not Otherwise Specified).

Bipolar I

In Bipolar I disorder, an individual has experienced one or more manic episodes with or without major depressive episodes. For a diagnosis of Bipolar I disorder according to the DSM-IV-TR, there requires one or more manic or mixed episodes. A depressive episode is not required for the diagnosis of Bipolar I disorder but it frequently occurs.

Bipolar II

Bipolar II disorder is characterized by more hypomanic episodes rather than actual manic episodes, as well as at least one major depressive episode. Hypomanic episodes usually do not go to the full extremes of mania (i.e. do not usually cause severe social or occupational impairment, and without psychosis), and this can make Bipolar II more difficult to diagnose, since the hypomanic episodes may simply appear as a period of successful high productivity and is reported less frequently than a distressing depression. For both disorders, there are a number of specifiers that indicate the presentation and course of the disorder, including "chronic", "rapid cycling", "catatonic" and "melancholic".

Cyclothymia

Cyclothymia involves a presence or history of hypomanic episodes with periods of depression that do not meet criteria for major depressive episodes. A diagnosis of Cyclothymic Disorder requires the presence of numerous hypomanic episodes, intermingled with depressive episodes that do not meet full criteria for major depressive episodes. The main idea here is that there is a low-grade cycling of mood which appears to the observer as a personality trait, but interferes with functioning.

Bipolar NOS

Bipolar Disorder Not Otherwise Specified is a catch-all diagnosis that is used to indicate bipolar illness that does not fit into the other diagnostic categories. If an individual clearly seems to be suffering from some type of bipolar disorder but does not meet the criteria for one of the subtypes above, he or she receives a diagnosis of Bipolar Disorder NOS (Not Otherwise Specified).

Rapid cycling

Most people who meet criteria for bipolar disorder experience a number of episodes, on average 0.4 to 0.7 per year, lasting three to six months.[12][13]

Rapid cycling, however, is a course specifier that may be applied to any of the above subtypes. It is defined as having four or more episodes per year and is found in a significant fraction of individuals with bipolar disorder. The definition of rapid cycling most frequently cited in the literature (including the DSM) is that of Dunner and Fieve: at least four major depressive, manic, hypomanic or mixed episodes are required to have occurred during a 12-month period.[14] There are references that describe very rapid (ultra-rapid) or extremely rapid[15] (ultra-ultra or ultradian) cycling. One definition of ultra-ultra rapid cycling is defining distinct shifts in mood within a 24–48-hour period.

Diagnostic challenges

The behavioral manifestations of bipolar disorder are often not understood by individuals or recognized by mental health professionals, so diagnosis may sometimes be delayed for 10 years or more.[16] That treatment lag is apparently not decreasing, even though there is now increased public awareness of this mental health condition in popular magazines and health websites. Recent TV specials, for example the BBC's The Secret Life of the Manic Depressive,[17] MTV's True Life: I'm Bipolar, talk shows, and public radio shows, and the greater willingness of public figures to discuss their own bipolar disorder, have focused on psychiatric conditions thereby further raising public awareness. Despite this increased focus, individuals are still commonly misdiagnosed.[18]

An individual may appear simply depressed when they are seen by a health professional. This can result in misdiagnosis of Major Depressive Disorder and harmful treatments. Recent screening tools such as the Hypomanic Check List Questionnaire (HCL-32) have been developed to assist the quite often difficult detection of Bipolar II disorders.

Flux is the fundamental nature of bipolar disorder.[19] Individuals with the illness have continual changes in energy, mood, thought, sleep, and activity. The diagnostic subtypes of bipolar disorder are thus static descriptions — snapshots, perhaps — of an illness in continual flux, with a great diversity of symptoms and varying degrees of severity. Individuals may stay in one subtype, or change into another, over the course of their illness (Goodwin & Jamison, 1990). The DSM V, to be published in 2012, will likely include further and more accurate sub-typing (Akiskal and Ghaemi, 2006).

Associated features

Associated features are clinical phenomenon that often accompany the disorder, but are not part of the diagnostic criteria for the disorder.

Cognitive impairment

Recent studies have found that bipolar disorder involves certain cognitive deficits or impairments, even in states of remission.[20][21][22][23][24]

It is not known whether specific cognitive deficits are mood state dependent or disorder-specific features of bipolar disorder. Few studies have examined impairments throughout all the different mood states, and many studies show conflicting data compared to other studies on account of methodological differences. Furthermore, the presence of mixed mood states complicates the identification of accurate cognitive models for this condition. Some use theories that conform to the cognitive models for unipolar depression and others on theories that focus solely on physiological or biological aspects of mania. However, Deborah Yurgelun-Todd of McLean Hospital in Belmont, Massachusetts has argued that some deficits should be included as a core feature of bipolar disorder. According to McIntyre et al. (2006),

Study results now press the point that neurocognitive deficits are a primary feature of BD; they are highly prevalent and persist in the absence of overt symptomatology. Although disparate neurocognitive abnormalities have been reported, disturbances in attention, visual memory, and executive function are most consistently reported.[25]

However, in the April–June 2007 issue of the Journal of Psychiatric Research (41, 3–4, 265–272) Spanish researchers (Selva et al.) reported that people with bipolar I who have a history of psychotic symptoms do not necessarily experience an increase in cognitive impairment. Some individuals diagnosed with bipolar I may experience only mood-congruent psychotic symptoms which may suggest a less severe prognosis, but this is by no means conclusive.

Creativity and accomplishment

While the disorder affects people differently, individuals with bipolar disorder during the manic phase tend to be much more outgoing and daring than individuals without bipolar disorder. The disorder is also found in a large number of people involved in the arts.[26] It is an ongoing question as to why many creative geniuses had bipolar disorder. Some studies have found a significant correlation between creativity and bipolar disorder. Though studies consistently show a positive correlation between the two, although it is unclear in which direction the cause lies, or whether both conditions are caused by a third unknown factor. Temperament has been hypothesized to be one such factor.[27][28][29]

A series of authors have described mania or hypomania as related to higher accomplishment, elevated achievement motivation and ambitious goal setting. One study indicated that greater-than-average striving for goals, and sometimes obtaining them, corresponded with mania.[30]

Epidemiology

The lifetime prevalence of bipolar disorder type I, which includes at least a lifetime manic episode, has generally been estimated at 1%.[31] Data from the landmark Epidemiologic Catchment Area study from the United States, however, suggests that 0.8 percent experience a manic episode at least once (the diagnostic threshold for bipolar I) and 0.5 a hypomanic episode (the diagnostic threshold for bipolar II or cyclothymia). Including sub-threshold diagnostic criteria, such as one or two symptoms over a short time-period, an additional 5.1 percent of the population, adding up to a total of 6.4 percent, can be thought of as having a bipolar spectrum disorder. This and similar recent studies have been interpreted by some prominent bipolar disorders researchers as evidence for a much higher prevalence of bipolar conditions in the general population than previously thought, although there are conceptual and methodological limitations to the findings. Prevalence studies of bipolar disorder are typically carried out by lay interviewers who follow fully structured/fixed interview schemes; responses to single items from such interviews may suffer limited validity.[32] In addition, diagnosis and prevalence rates are dependent on whether a categorical or spectrum approach is taken, and concerns have arisen about the potential for both underdiagnosis and overdiagnosis.[33]

Late adolescence and early adulthood are peak years for the onset of bipolar disorder.[34][35] These are critical periods in a young adult's social and vocational development, and they can be severely disrupted.

Major depressive disorder and bipolar disorder are currently classified as separate disorders. Some researchers increasingly view them as part of an overlapping spectrum that also includes anxiety and psychosis. According to Hagop Akiskal, M.D., at the one end of the spectrum is bipolar type schizoaffective disorder, and at the other end is unipolar depression (recurrent or not recurrent), with the anxiety disorders present across the spectrum. Also included in this view is premenstrual dysphoric disorder, postpartum depression, and postpartum psychosis. This view helps to explain why many people who have the illness do not have first-degree relatives with clear-cut "bipolar disorder", but who have family members with a history of these other disorders.

Children

Bipolar disorder in children has generally been considered very rare, and its diagnosis is controversial. Onset prior to age 10 has been found in only an estimated 0.3% to 0.5% of bipolar patients, although some case studies suggest higher figures.[36] Children who show some bipolar symptoms tend to have a rapid-cycling or mixed-cycling pattern that may not meet DSM-IV criteria.Cite error: The <ref> tag has too many names (see the help page). It can be difficult to distinguish between age-appropriate restlessness, the fidgeting of children with ADHD, and the purposeful busy activity of mania.[37] Further complicating the diagnosis: Abused or traumatized children can seem to have bipolar disorder when they are actually reacting to horrors in their lives.[38]

Nevertheless, findings indicate that the number of American children and adolescents treated for bipolar disorder increased 40-fold from 1994 to 2003, and was continuing to increase. The data suggest that doctors had been more aggressively applying the diagnosis to children, rather than that the incidence of the disorder has increased. The study calculated the number of psychiatric visits increased from 20,000 in 1994 to 800,000 in 2003, or 1% of the population under age 20.[39][40] Assumptions regarding behavior, particularly in regard to diagnosing bipolar disorder, ADHD, and mania in children and adolescents, have raised considerable questions regarding unnecessary treatment, especially as antipsychotic drugs sometimes prescribed for the treatment of BD may increase risk to health including heart problems, diabetes, liver failure, and death.[41]

Older age

As the population of some countries ages, the number of older adults with mental disorders is set to increase, but there is a relative lack of knowledge about bipolar disorder in late life. A review did find relatively strong evidence that bipolar disorder becomes less prevalent with age, but nevertheless accounts for a similar percentage of psychiatric admissions; that older bipolar patients had first experienced symptoms at a later age; that later onset of mania is associated with more neurologic impairment; that substance abuse is considerably less common in older groups; and that there is probably a greater degree of variation in presentation and course, for instance individuals may develop new-onset mania associated with vascular changes, or become manic only after recurrent depressive episodes, or may have been diagnosed with bipolar disorder at an early age and still meet criteria. There is also weak evidence of a higher prevalence of mixed episodes in older adults and a lower treatment response, although mania may be less intense. Overall there are likely more similarities than differences from younger adults.[42]

Causes

Bipolar disorder is not either environmental or physiological, it is multifactorial; that is, many genes and environmental factors conspire to create the disorder (Johnson & Leahy, 2004). Since bipolar disorder is so heterogeneous, it is likely that people experience different pathways towards the illness (Miklowitz & Goldstein, 1997). Bipolar disorder tends to run in families.[43] More than two-thirds of people with bipolar disorder have at least one close relative with the disorder or with unipolar major depression.[citation needed]

The monozygotic concordance rate for the disorder is 70%. This means that if a person has the disorder, an identical twin has a 70% likelihood of having the disorder as well. Dizygotic twins have a 23% concordance rate. These concordance rates are not universally replicated in the literature; recent studies have shown rates of around 40% for monozygotic and less than 10% for dizygotic twins (see Kieseppa, 2004 and Cardno, 1999).[44][45]

Genetic

There is increasing evidence for a genetic component in the causation of bipolar disorder, provided by a number of twin studies and gene linkage studies. Researchers have been searching for specific genes passed down through generations that may increase a person's chance of developing the disorder. Findings from gene research suggest that bipolar disorder, like other mental disorders, does not occur because of a single gene.[46] However, it is well established that bipolar disorder is a genetically influenced condition (Johnson & Leahy, 2004; Miklowitz & Goldstein, 1997; Frank, 2005).

A family history of bipolar spectrum disorders can impart a genetic predisposition towards developing a bipolar spectrum disorder.[47] Since bipolar disorders are polygenic (involving many genes), there are apt to be many unipolar and bipolar disordered individuals in the same family pedigree. This is very often the case (Barondes, 1998). Anxiety disorders, clinical depression, eating disorders, premenstrual dysphoric disorder, postpartum depression, postpartum psychosis schizoaffective disorder and/or schizophrenia may be part of the patient's family history and reflects a term called "genetic loading". A recent Swedish study, by Karolinska Institutet, links children with older fathers to a major risk of suffering from bipolar disorder.[48]

In 2003, a group of American and Canadian researchers published a paper that used gene linkage techniques to identify a mutation in the GRK3 gene as a possible cause of up to 10% of cases of bipolar disorder. This gene is associated with a kinase enzyme called G protein receptor kinase 3, which appears to be involved in dopamine metabolism, and may provide a possible target for new drugs for bipolar disorder.[49]

A 2007 gene-linkage study by an international team coordinated by the NIMH has identified a number of genes as likely to be involved in the etiology of bipolar disorder, suggesting that bipolar disorder may be a polygenic disease. The researchers at NIMH have found a correlation between DGKH (diacylglycerol kinase eta) and bipolar disorder. The portion of the genome that encodes DGKH, a key protein in the lithium-sensitive phosphatidyl inositol pathway.[50]

In 2008, one study detected association of PPARD gene polymorphisms with bipolar disorder.[51] The cadherin gene FAT has been linked to bipolar disorder.[52]

Bipolar disorder has been linked to mutations in the G protein receptor kinase (GRK3) gene—which regulates sensitivity to brain neurotransmitters such as dopamine.[53] In 1997 a genome survey was completed and Kelsoe and colleges reported that, “results support the presence of a susceptibility locus for bipolar disorder on chromosome 22…These molecular data raise the possibility that common susceptibility genes may be involved.”[54]

One review of the case histories of approximately 500 patients found that bipolar disorder was related to a significantly higher occurence of mitral valve prolapse (MVP), temporomandibular joint disease (TMJ), and scoliosis. It was hypothesized that genetic sites involved in bipolar disorder may be in close proximity to genes related to TMJ, MVP and scoliosis, although this work was conducted in the years 1989-1990 and has not yet been replicated for verification.[55]

Childhood

Individuals with late-adolescent/early adult onset of the disorder will very likely have experienced childhood anxiety and depression. Some argue that childhood-onset bipolar disorder should be treated when it occurs to prevent the full development of the disorder.

Neural

Researchers hypothesize that abnormalities in the structure and/or function of certain brain circuits could underlie bipolar and other mood disorders. Studies have found anatomical differences in areas such as the amygdala,[56] prefrontal cortex[57] and hippocampus. A meta-analysis of 98 structural imaging studies reported that patients with bipolar disorder had lateral ventricles which were 17% larger than controls and patients were 2.5 times more likely to have deep white matter hyperintensities.[58]

The "kindling" theory asserts that people who are genetically predisposed toward bipolar disorder can experience a series of stressful events,[59] each of which lowers the threshold at which mood changes occur. Eventually, a mood episode can start (and become recurrent) by itself. There is evidence of hypothalamic-pituitary-adrenal axis (HPA axis) abnormalities in bipolar disorder due to stress.[60]

Recent research in Japan hypothesizes that dysfunctional mitochondria in the brain may play a role (Stork & Renshaw, 2005).

Life events

When faced with a very stressful, negative major life event, such as a failure in an important area, an individual may have his first major depression. Conversely, when an individual accomplishes a major achievement he may experience his first hypomanic or manic episode. Individuals with bipolar disorder tend to experience episode triggers involving either interpersonal or achievement-related life events. An example of interpersonal-life events include falling in love or, conversely, the death of a close friend. Achievement-related life events include acceptance into an elite graduate school or by contrast, being fired from work (Miklowitz & Goldstein, 1997). Childbirth can also trigger a postpartum psychosis for bipolar women, which can lead in the worst cases to infanticide. Some individuals experience subsequent mood episodes in the absence of positive or negative life events, however.

Treatment

Bipolar disorder cannot be cured; instead, the emphasis of treatment is on effective management of acute episodes and prevention of further episodes by use of pharmacological and psychotherapeutic techniques.

Hospitalization may occur, especially with manic episodes. This can be voluntary or (if mental health legislation allows it) involuntary (called civil or involuntary commitment). Long-term inpatient stays are now less common due to deinstitutionalization, although can still occur.[61] Following (or in lieu of) a hospital admission, support services available can include drop-in centers, visits from members of a community mental health team or Assertive Community Treatment team, supported employment and patient-led support groups.[62]

Medication

The mainstay of treatment is a mood stabilizer medication; these comprise several unrelated compounds which have been shown to be effective in preventing relapses of manic, or in the one case, depressive episodes. The first known and "gold standard" mood stabilizer is lithium,[63] while almost as widely used is sodium valproate,[64] originally used as an anticonvulsant. Other anticonvulsants used in bipolar disorder include carbamazepine, reportedly more effective in rapid cycling bipolar disorder, and lamotrigine, which is the first anticonvulsant shown to be of benefit in bipolar depression.[65]

Treatment of the agitation in acute manic episodes has often required the use of antipsychotic medications, such as Quetiapine, Olanzapine and Chlorpromazine. More recently, Olanzapine and Quetiapine have been approved as effective monotherapy for the maintenance of bipolar disorder.[66] A head-to-head randomized control trial in 2005 has also shown olanzapine monotherapy to be as effective and safe as lithium in prophylaxis.[67]

The use of antidepressants in bipolar disorder has been debated, with some studies reporting a worse outcome with their use triggering manic, hypomanic or mixed episodes, especially if no mood stabiliser is used. However, most mood stabilizers are of limited effectiveness in depressive episodes. Rapid cycling can be induced or made worse by antidepressants, unless there is adjunctive treatment with a mood stabilizer.[68][69] One large-scale study found that depression in bipolar disorder responds no better to an antidepressasnt with mood stabilizer than it does to a mood stabilizer alone.[70]

Psychological

Psychological factors also play a strong role in both the psychopathology of the disorder and the psychotherapeutic factors aimed at alleviating core symptoms, recognizing episode triggers, reducing negative expressed emotion in relationships, recognizing prodromal symptoms before full-blown recurrence, and, practising the factors that lead to maintenance of remission (Lam et al, 1999; Johnson & Leahy, 2004; Basco & Rush, 2005; Miklowitz & Goldstein, 1997; Frank, 2005). Modern evidence based psychotherapies designed specifically for bipolar disorder when used in combination with standard medication treatment increase the time the individual stays well significantly longer than medications alone (Frank, 2005). These psychotherapies are interpersonal and social rhythm therapy for bipolar disorder, family focused therapy for bipolar disorder, psychoeducation, cognitive therapy for bipolar disorder, and prodrome detection.

Prognosis

For some, good prognosis results from good treatment, which, in turn, results from an accurate diagnosis. Because bipolar disorder continues to have a high rate of both under-diagnosis and misdiagnosis, it is often difficult for individuals with the condition to receive timely and competent treatment.

Bipolar disorder can be a severely disabling medical condition. However, many individuals with bipolar disorder can live full and satisfying lives. Sometimes medication is needed to enable this. Persons with bipolar disorder are likely to have periods of normal or near normal functioning between episodes.

Ultimately one's prognosis depends on many factors, which may, in fact, be under the individual's control, these may include: the right medicines; the right dose of each; a very informed patient; a good working relationship with a competent medical doctor; a competent, supportive and warm therapist; a supportive family or significant other; and a balanced lifestyle including a regulated stress level, regular exercise and regular sleep and wake times.

There are obviously other factors that lead to a good prognosis as well, such as being very aware of small changes in one's energy, mood, sleep and eating behaviors, as well as having a plan in conjunction with one's doctor for how to manage subtle changes that might indicate the beginning of a mood swing. Some people find that keeping a log of their moods can assist them in predicting changes.[71]

Functioning

A recent 20-year prospective study on bipolar I and II has been described as having characterized bipolar by "a low rate of recovery, a high rate of recurrence, and poor interepisodic functioning."[72] However, the study did not report recovery or recurrence rates but that functioning varied along a spectrum from good to fair to poor, and only with periods of major depression or mania (in BPI) was it poor; that depression was more persistantly associated with disability than mania; that interepisodic functioning was near normal; and that subsyndromal symptoms were generally still substantially impairing, although subsyndromal and symptom-level hypomania in BPII was associated with improved functioning.[73]

Another study confirmed the seriousness of the disorder as "the standardized all-cause mortality ratio among patients with BD is increased approximately 2-fold." Bipolar disorder is currently regarded "as possibly the most costly category of mental disorders in the United States." Episodes of abnormality are associated with distress and disruption, and an elevated risk of suicide, especially during depressive episodes. [74]

Recovery

A naturalistic study from first admission for mania or mixed episode (representing the hospitalized and therefore most severe cases) found that 50% achieved syndromal recovery (no longer meeting criteria for the diagnosis) within six weeks and 98% within two years. 72% achieved symptomatic recovery (no symptoms at all) and 43% achieved functional recovery (regaining of prior occupational and residential status). However, 40% went on to experience a new episode of mania or depression within 2 years of syndromal recovery, and 19% switched phases without recovery.[75]

Recurrence

The following behaviors can lead to depressive or manic recurrence:

  • Discontinuing or lowering one's dose of medication, without consulting one's physician.
  • Being under- or over-medicated. Generally, taking a lower dosage of a mood stabilizer can lead to relapse into mania. Taking a lower dosage of an antidepressant, may cause the patient to relapse into depression, while higher doses can cause destabilization into mixed-states or mania.
  • An inconsistent sleep schedule can destabilize the illness. Too much sleep (possibly caused by medication) can lead to depression, while too little sleep can lead to mixed states or mania.
  • Caffeine can cause destabilization of mood toward irritability, dysphoria, and mania. Anecdotal evidence seems to suggest that lower dosages of caffeine can have effects ranging from anti-depressant to mania-inducing.
  • Inadequate stress management and poor lifestyle choices. If unmedicated, excessive stress can cause the individual to relapse. Medication raises the stress threshold somewhat, but too much stress still causes relapse.
  • Often bipolar individuals are subject to self-medication, the most common drugs being alcohol, and marijuana. Sometimes they may also turn to hard drugs, which can cause the condition to worsen. Studies show that tobacco smoking induces a calming effect on most bipolar people, and a very high percentage suffering from the disorder smoke.[76]

Recurrence can be managed by the sufferer with the help of a close friend, based on the occurrence of idiosyncratic prodromal events.[77] This theorizes that a close friend could notice which moods, activities, behaviours, thinking processes, or thoughts typically occur at the outset of bipolar episodes. They can then take planned steps to slow or reverse the onset of illness, or take action to prevent the episode from being damaging.[78] These sensitivity triggers show some similarity to traits of a highly sensitive person.

Mortality

"Mortality studies have documented an increase in all-cause mortality in patients with BD. A newly established and rapidly growing database indicates that mortality due to chronic medical disorders (eg, cardiovascular disease) is the single largest cause of premature and excess deaths in BD. The standardized mortality ratio from suicide in BD is estimated to be approximately 18 to 25, further emphasizing the lethality of the disorder."[79]

Although many people with bipolar disorder who attempt suicide never actually complete it, the annual average suicide rate in males and females with diagnosed bipolar disorder (0.4%) is 10 to more than 20 times that in the general population.[80]

Individuals with bipolar disorder may become suicidal, especially during mixed states such as dysphoric mania and agitated depression.[81] Persons suffering from Bipolar II have high rates of suicide compared to persons suffering from other mental health conditions, including Major Depression. Major Depressive episodes are part of the Bipolar II experience, and there is evidence that sufferers of this disorder spend proportionally much more of their life in the depressive phase of the illness than their counterparts with Bipolar I Disorder (Akiskal & Kessler, 2007).

History

Varying moods and energy levels have been a part of the human experience since time immemorial. The words "melancholia" (an old word for depression) and "mania" have their etymologies in Ancient Greek. The word melancholia is derived from melas/μελας, meaning "black", and chole/χολη, meaning "bile" or "gall",[82] indicative of the term’s origins in pre-Hippocratic humoral theories. Within the humoral theories, mania was viewed as arising from an excess of yellow bile, or a mixture of black and yellow bile. The linguistic origins of mania, however, are not so clear-cut. Several etymologies are proposed by the Roman physician Caelius Aurelianus, including the Greek word ‘ania’, meaning to produce great mental anguish, and ‘manos’, meaning relaxed or loose, which would contextually approximate to an excessive relaxing of the mind or soul (Angst and Marneros 2001). There are at least five other candidates, and part of the confusion surrounding the exact etymology of the word mania is its varied usage in the pre-Hippocratic poetry and mythologies (Angst and Marneros 2001).

The idea of a relationship between mania and melancholia can be traced back to at least the 2nd century AD.[citation needed] Soranus of Ephesus (98–177 AD) described mania and melancholia as distinct diseases with separate etiologies;[83] however, he acknowledged that “many others consider melancholia a form of the disease of mania” (Cited in Mondimore 2005 p.49).

A clear understanding of bipolar disorder as a mental illness was recognized by early Chinese authors. The encyclopedist Gao Lian (c. 1583) describes the malady in his Eight Treatises on the Nurturing of Life (Ts'un-sheng pa-chien).[84]

The earliest written descriptions of a relationship between mania and melancholia are attributed to Aretaeus of Cappadocia. Aretaeus was an eclectic medical philosopher who lived in Alexandria somewhere between 30 and 150 AD (Roccatagliata 1986; Akiskal 1996). Aretaeus is recognized as having authored most of the surviving texts referring to a unified concept of manic-depressive illness, viewing both melancholia and mania as having a common origin in ‘black bile’ (Akiskal 1996; Marneros 2001).

Avicenna, a Persian physician and psychological thinker who wrote The Canon of Medicine in 1025, identified bipolar disorder as a manic depressive psychosis, which he clearly distinguished from other forms of madness (Junun) such as as mania, rabies, and schizophrenia (Junun Mufrit or severe madness).[85]

File:Emil Kraepelin.png
Emil Kraepelin (1856–1926) refined the concept of psychosis.

The basis of the current conceptualisation of manic-depressive illness can be traced back to the 1850s; on January 31, 1854, Jules Baillarger described to the French Imperial Academy of Medicine a biphasic mental illness causing recurrent oscillations between mania and depression, which he termed folie à double forme (‘dual-form insanity’). Two weeks later, on February 14, 1854, Jean-Pierre Falret presented a description to the Academy on what was essentially the same disorder, and designated folie circulaire (‘circular insanity’) by him.(Sedler 1983) The two bitterly disputed as to who had been the first to conceptualise the condition.

These concepts were developed by the German psychiatrist Emil Kraepelin (1856–1926), who, using Kahbaum concept of cyclothymia,[86] categorized and studied the natural course of untreated bipolar patients. He coined the term manic depressive psychosis, after noting that periods of acute illness, manic or depressive, were generally punctuated by relatively symptom-free intervals where the patient was able to function normally.[87]

After World War II, Dr. John Cade, an Australian psychiatrist, was investigating the effects of various compounds on veteran patients with manic depressive psychosis. In 1949, Cade discovered that lithium carbonate could be used as a successful treatment of manic depressive psychosis.[88] Because there was a fear that table salt substitutes could lead to toxicity or death, Cade's findings did not immediately lead to treatments. In the 1950s, U.S. hospitals began experimenting with lithium on their patients. By the mid-'60s, reports started appearing in the medical literature regarding lithium's effectiveness. The U.S. Food and Drug Administration did not approve of lithium's use until 1970.[89]

The term "manic-depressive reaction" appeared in the first American Psychiatric Association Diagnostic Manual in 1952, influenced by the legacy of Adolf Meyer who had introduced the paradigm illness as a reaction of biogenetic factors to psychological and social influences.[90] Subclassification of bipolar disorder was first proposed by German psychiatrist Karl Leonhard in 1957; he was also the first to introduce the terms bipolar (for those with mania) and unipolar (for those with depressive episodes only).[91]

In 1968, both the newly revised classification systems ICD-8 and DSM-II termed the condition "manic-depressive illness" as biological thinking came to the fore.[92]

The current nosology, bipolar disorder, became popular only recently, and some individuals prefer the older term because it provides a better description of a continually changing multi-dimensional illness.[citation needed]

Sociological and cultural aspects

Cultural references

Kay Redfield Jamison is a clinical psychologist and Professor of Psychiatry at the Johns Hopkins University School of Medicine, who profiled her own bipolar disorder in her 1995 memoir An Unquiet Mind and argued for a connection between bipolar disorder and artistic creativity in her 1993 book, Touched with Fire.

Several films have portrayed characters with traits strongly suggestive of the diagnosis which have been the subject of discussion by psychiatrists and film experts alike. The 1993 film Mr. Jones is a notable example, with Richard Gere playing a person who swings from a manic episode into a depressive phase and back again, spending time in a psychiatric hospital and displaying many of the features of the syndrome.[93] Allie Fox, the character played by Harrison Ford in the 1992 movie The Mosquito Coast, displays some features including recklessness, grandiosity, increased goal-directed activity and mood lability, as well as some paranoia.[94]

In the NBC drama ER, series of episodes follow Maura Tierney's Abby Lockhart character's relation with her bipolar mother Maggie[95], and later her brother, who had been misdiagnosed with depression, but who in fact had inherrited BD from Maggie [96].

See also

References

  1. ^ "Bipolar Disorder: Signs and symptoms". Mayo Clinic.
  2. ^ NIMH · Bipolar Disorder · Complete Publication
  3. ^ NIMH · Bipolar Disorder · Complete Publication
  4. ^ "Bipolar Disorder: Complications". Mayo Clinic.
  5. ^ Pope HG (1983). "Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports". Hospital and Community Psychiatry. 34: 322–28.
  6. ^ Goodwin & Jamison. pp. 108–110.
  7. ^ Akiskal HS, Yerevanian BI, Davis GC, King D, Lemmi H (1985). "The nosologic status of borderline personality: clinical and polysomnographic study". Am J Psychiatry. 142 (2): 192–8. PMID 3970243. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  8. ^ Gunderson JG, Elliott GR (1985). "The interface between borderline personality disorder and affective disorder". Am J Psychiatry. 142: 277–288.
  9. ^ McGlashan, TH (1983). "The borderline syndrome:Is it a variant of schizophrenia or affective disorder?". Arch Gen Psychiatry. 40: 1319–1323.
  10. ^ Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Gunderson JG (1983). "The validity of DSM-III borderline personality disorder: A phenomenologic, family history, treatment response, and long term follow up study". Arch Gen Psychiatry. 40: 23–30.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Akiskal HS, Benazzi F (2006). "The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum". J Affect Disord. 92 (1): 45–54. doi:10.1016/j.jad.2005.12.035. PMID 16488021. {{cite journal}}: Unknown parameter |month= ignored (help)
  12. ^ Kessler, RC; McGonagle, KA; Zhao, S; Nelson, CB; Hughes, M; Eshleman, S; Wittchen, HU; Kendler, KS (1994), "Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States", Archives of General Psychiatry, 51 (1): 8–19, doi:10.1001/archpsyc.51.1.8, PMID 8279933 {{citation}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  13. ^ Angst, J; Selloro, R (September 15, 2000), "Historical perspectives and natural history of bipolar disorder", Biological Psychiatry, 48 (6): 445–457, doi:10.1016/S0006-3223(00)00909-4
  14. ^ Mackin, P; Young, AH (2004), "Rapid cycling bipolar disorder: historical overview and focus on emerging treatments", Bipolar Disorders, 6 (6): 523–529, doi:10.1111/j.1399-5618.2004.00156.x
  15. ^ Papolos, DF; Veit, S; Faedda, GL; Saito, T; Lachman, HM (1998), "Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele", Molecular Psychiatry, 3 (4): 346–349, doi:10.1038/sj.mp.4000410
  16. ^ S. Nassir Ghaemi (2001). "Bipolar Disorder: How long does it usually take for someone to be diagnosed for bipolar disorder?". Retrieved 2007-02-20.
  17. ^ "The Secret Life of the Manic Depressive". BBC. 2006. Retrieved 2007-02-20.
  18. ^ Roy H. Perlis (2005). "Misdiagnosis of Bipolar Disorder". Retrieved 2007-02-20. {{cite web}}: Unknown parameter |publication= ignored (help)
  19. ^ Depression and Bipolar Support Alliance: About Mood Disorders
  20. ^ Martínez-Arán, A; Vieta, E; Reinares, M; Colom, F; Torrent, C; Sánchez-Moreno, J; Benabarre, A; Goikolea, JM; Comes, M; Salamero, M (February 2004), "Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder", American Journal of Psychiatry, 161 (2): 262–270, doi:10.1176/appi.ajp.161.2.262, PMID 14754775{{citation}}: CS1 maint: date and year (link)
  21. ^ Rossi, A; Arduini, L; Daneluzzo, E; Bustini, M; Prosperini, P; Stratta, P (July 2000), "Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls", Journal of Psychiatric Research, 34 (4–5): 333–339, doi:10.1016/S0022-3956(00)00025-X{{citation}}: CS1 maint: date and year (link)
  22. ^ "Second Biennial Conference of the International Society for Bipolar Disorders, 2–August 4, 2006, Edinburgh, Scotland, Thursday, August 3, 09:00–10:00, Cognitive Function in BD", Bipolar Disorders, 8 (Supplement 1): 2–3, August 2006, doi:10.1111/j.1399-5618.2006.00379_2.x
  23. ^ Zubieta, J-K; Huguelet, P; O'Neil, RL; Giordani, BJ (May 10, 2001), "Cognitive function in euthymic Bipolar I Disorder", Psychiatry Research, 102 (1): 9–20, doi:10.1016/S0165-1781(01)00242-6
  24. ^ Kerr, N; Scott, J; Phillips, M (2005), "Patterns of attentional deficits and emotional bias in bipolar disorder and major depressive disorder", British Journal of Clinical Psychology, 44: 343–356, doi:10.1348/014466505X57755 {{citation}}: line feed character in |title= at position 50 (help)
  25. ^ Roger S. McIntyre, MD, Joanna K. Soczynska, and Jakub Konarski (2006). "Bipolar Disorder: Defining Remission and Selecting Treatment". Psychiatric Times. {{cite journal}}: Unknown parameter |cite= ignored (help)CS1 maint: multiple names: authors list (link)
  26. ^ ["http://people.howstuffworks.com/mad-genius3.htm" "Mad Genius"]. HowStuffWorks. Retrieved 2008-09-08. {{cite web}}: Check |url= value (help)
  27. ^ Santosa et al. Enhanced creativity in bipolar disorder patients: A controlled study. J Affect Disord. 2006 November 23; PMID 17126406.
  28. ^ Rihmer et al. Creativity and mental illness. Psychiatr Hung. 2006;21(4):288–94. PMID 17170470.
  29. ^ Nowakowska et al. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. J Affect Disord. 2005 Mar;85(1–2):207–15. PMID 15780691.
  30. ^ Johnson SL (2005). "Mania and dysregulation in goal pursuit: a review". Clin Psychol Rev. 25 (2): 241–62. doi:10.1016/j.cpr.2004.11.002. PMID 15642648. {{cite journal}}: Unknown parameter |month= ignored (help)
  31. ^ Soldani, Federico (2005). "Mania in the Swedish Twin Registry: criterion validity and prevalence". Australian and New Zealand of Psychiatry. 39 (4): 235–43. doi:10.1111/j.1440-1614.2005.01559.x. PMID 15777359. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  32. ^ Judd, Lewis L. (2003). "The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases". Journal of Affective Disorders. 73 (1–2): 123–31. doi:10.1016/S0165-0327(02)00332-4. PMID 12507745. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  33. ^ Phelps, J. (2006) Bipolar Disorder: Particle or Wave? DSM Categories or Spectrum Dimensions? Psychiatric Times
  34. ^ Christie KA, Burke JD Jr, Regier DA, Rae DS, Boyd JH, Locke BZ (1988). (abstract) "Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults". Am J Psychiatry. 145: 971–975. Retrieved 2007-07-01. {{cite journal}}: Check |url= value (help)CS1 maint: multiple names: authors list (link)
  35. ^ Goodwin & Jamison. p. 121.
  36. ^ American Academy of Child and Adolescent Psychiatry (1997)Practice Parameters for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder
  37. ^ Naomi A. Schapiro Bipolar Disorders in Children and Adolescents J Pediatr Health Care. 2005;19(3):131-141.
  38. ^ [http://www.boston.com/news/local/massachusetts/articles/2007/02/15/bipolar_labels_for_children_stir_concern/?page=2 Bipolar labels for children stir concern - The Boston Globe
  39. ^ New York Times, Bipolar Illness Soars as a Diagnosis for the Young
  40. ^ Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. (September 2007) "National trends in the outpatient diagnosis and treatment of bipolar disorder in youth," Archives of General Psychiatry. 64(9):1032–9. PMID 17768268
  41. ^ [http://www.usatoday.com/news/health/2006-05-01-atypical-drugs_x.htm USATODAY.com - New antipsychotic drugs carry risks for children
  42. ^ Depp CA, Jeste DV. (2004) Bipolar disorder in older adults: a critical review Bipolar Disord. 2004 Oct;6(5):343-67.
  43. ^ McGuffin, P; Rijsdijk, F; Andrew, M; Sham, P; Katz, R; Cardno, A (2003), "The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression", Archives of General Psychiatry, 60 (5): 497–502, doi:10.1001/archpsyc.60.5.497, PMID 12742871
  44. ^ Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J (2004). "High concordance of bipolar I disorder in a nationwide sample of twins". Am J Psychiatry. 161 (10): 1814–21. doi:10.1176/appi.ajp.161.10.1814. PMID 15465978. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  45. ^ Cardno AG, Marshall EJ, Coid B; et al. (1999). "Heritability estimates for psychotic disorders: the Maudsley twin psychosis series". Arch. Gen. Psychiatry. 56 (2): 162–8. PMID 10025441. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  46. ^ NIMH. "What Causes Bipolar Disorder?".
  47. ^ Genetics and Risk PsychEducation.org
  48. ^ TheLocal.se:"Swedish study links bipolar disorder to older fathers"
  49. ^ Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Alexander M, Shaw SH, Kelsoe JR. (2003). "Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder". Molecular Psychiatry. 8 (5): 546–57. doi:10.1038/sj.mp.4001268. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  50. ^ Baum, A E; McMahon, F J (May 8, 2007), "A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder" ([dead link]Scholar search), Molecular Psychiatry {{citation}}: External link in |format= (help)CS1 maint: date and year (link)
  51. ^ Zandi PP, Belmonte PL, Willour VL; et al. (2008). "Association study of Wnt signaling pathway genes in bipolar disorder". Arch. Gen. Psychiatry. 65 (7): 785–93. doi:10.1001/archpsyc.65.7.785. PMID 18606951. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  52. ^ Emma Young (2006). "New gene linked to bipolar disorder". New Scientist. {{cite web}}: Unknown parameter |accessyear= ignored (|access-date= suggested) (help)
  53. ^ …”(“Role for gene in bipolar disorder.” The Lancet June 22, 2003: 2137.
  54. ^ A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22 - Kelsoe et al. 98 (2): 585 - Proceedings of the National Academy of Sciences
  55. ^ AJ Giannini, AE Slaby, JP Gianetti, MS Darosky, CB Wagomun, J Feather, DF Folts. Correlates on physical examination of bipolar patients. Turkish Journal of Biological and Medical Research. 2(1):23-29, 1991.
  56. ^ Strakowski, S.M., DelBello, M.P, Sax, K.W. et. al. (1999). "Brain magnetic resonance imaging of structural abnormalities in bipolar disorder," Archives of General Psychiatry, 56:254–60.
  57. ^ Prefrontal Cortex in Bipolar Disorder Neurotransmitter.net.
  58. ^ Kempton, M.J., Geddes, J.R, Ettinger, U. et. al. (2008). "Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder," Archives of General Psychiatry, 65:1017–1032 see also www.bipolardatabase.org.
  59. ^ Link and reference involving kindling theory
  60. ^ Brian Koehler, Ph.D., The International Society for the Psychological Treatment Of Schizophrenia and Other Psychoses, Bipolar Disorder, Stress, and the HPA Axis, 2005.
  61. ^ Becker T, Kilian R. (2006) Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care? Acta Psychiatrica Scandinavica Supplement, 429, 9–16. PMID 16445476
  62. ^ McGurk, SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry. Mar;164(3):437–41. PMID 17329468
  63. ^ Poolsup N, Li Wan Po A, de Oliveira IR. (2000) Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 25: 139–156 PMID: 10849192
  64. ^ Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. (2002). (abstract) "Valproate for acute mood episodes in bipolar disorder". The Cochrane Database of Systematic Reviews (2). John Wiley and Sons, Ltd. doi:10.1002/14651858.CD004052. ISSN 1464-780X. {{cite journal}}: Check |url= value (help)CS1 maint: multiple names: authors list (link)
  65. ^ Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999). "A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group". J Clin Psychiatry. 60 (2): 79–88. PMID 10084633. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  66. ^ Now Approved: ZYPREXA for maintenance therapy for bipolar disorder. Official Zyprexa Website.
  67. ^ Tohen M, Greil W, Calabrese JR; et al. (2005). "Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial". Am J Psychiatry. 162 (7): 1281–90. doi:10.1176/appi.ajp.162.7.1281. PMID 15994710. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  68. ^ "Treatment of refractory and rapid-cycling bipolar disorder".
  69. ^ Sachs, GS, MD, et al (2007) Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression New England Journal of Medicine, Volume 356:1711–1722 (Abstract).
  70. ^ Bipolar surprise: mood disorder endures antidepressant setback. Science News, March 31, 2007, vol. 171, #13, p.196
  71. ^ "Introduction". cs.umd.edu. Retrieved 2008-02-16.
  72. ^ Roger S. McIntyre, MD, Joanna K. Soczynska, and Jakub Konarski "Bipolar Disorder: Defining Remission and Selecting Treatment" Vol. XXIII, No. 11 (October 2006)
  73. ^ JUDD Lewis L.; AKISKAL Hagop S.; SCHETTLER Pamela J. ; ENDICOTT Jean; LEON Andrew C.; SOLOMON David A.; CORYELL William; MASER Jack D.; KELLER Martin B. (2005) Psychosocial disability in the course of bipolar I and II disorders : A prospective, comparative, longitudinal study Archives of General Psychiatry, vol. 62, no12, pp. 1322-1330
  74. ^ Ösby, U; Brandt, L; Correia, N; Ekbom, A; Sparén, P (2001), "Excess Mortality in Bipolar and Unipolar Disorder in Sweden", Archives of General Psychiatry, 58 (9): 844–850, doi:10.1001/archpsyc.58.9.844, PMID 11545667
  75. ^ Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. (2003) The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence Am J Psychiatry. 2003 Dec;160(12):2099-107.
  76. ^ Bipolar Disorder
  77. ^ Perry A, Tarrier N, Morriss R, McCarthy E, Limb K (1999). "Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment". BMJ. 318 (7177): 149–53. PMC 27688. PMID 9888904. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  78. ^ Kelly, M., Bipolar and the Art of Roller-coaster Riding, Two Trees Media 2000, 2005
  79. ^ Roger S. McIntyre, MD, Joanna K. Soczynska, and Jakub Konarski. "Bipolar Disorder: Defining Remission and Selecting Treatment". Psychiatric Times, October 2006, Vol. XXIII, No. 11.{{cite web}}: CS1 maint: multiple names: authors list (link)
  80. ^ Leslie Citrome, MD, MPH; Joseph F. Goldberg, MD. "Bipolar disorder is a potentially fatal disease".{{cite web}}: CS1 maint: multiple names: authors list (link)
  81. ^ Psychopathologic Correlates of Suicidal Ideation in Major Depressive Outpatients: Is It All Due to Unrecognized (Bipolar) Depressive Mixed States?
  82. ^ Liddell, Henry George and Robert Scott (1980). A Greek-English Lexicon (Abridged Edition). United Kingdom: Oxford University Press. ISBN 0-19-910207-4.
  83. ^ "Bipolar_disorders_beyond_major_depression_and_euphoric_mania" (PDF). cambridge.org. Retrieved 2008-02-16.
  84. ^ http://www.nmh.gov.tw/nmh_web/english_version/exhibition/exhibition_s0703.cfm
  85. ^ Template:Harvard reference
  86. ^ Millon, Theordore (1996). Disorders of Personality: DSM-IV-TM and Beyond. New York: John Wiley and Sons. pp. p. 290. ISBN 0-471-01186-X. {{cite book}}: |pages= has extra text (help)
  87. ^ Kraepelin, Emil (1921) Manic-depressive Insanity and Paranoia ISBN 0-405-07441-7
  88. ^ Cade JF (1949). "Lithium salts in the treatment of psychotic excitement" (PDF). Med. J. Aust. 2 (10): 349–52. PMID 18142718. {{cite journal}}: Unknown parameter |month= ignored (help)
  89. ^ Mitchell PB, Hadzi-Pavlovic D (2000). "Lithium treatment for bipolar disorder" (PDF). Bull. World Health Organ. 78 (4): 515–7. PMID 10885179.
  90. ^ Goodwin & Jamison. pp. 60–61.
  91. ^ Goodwin & Jamison. p62
  92. ^ Goodwin & Jamison. p88
  93. ^ Robinson DJ. Reel Psychiatry:Movie Portrayals of Psychiatric Conditions. Port Huron, Michigan: Rapid Psychler Press. pp. p. 78-81. ISBN 1-894328-07-8. {{cite book}}: |pages= has extra text (help)
  94. ^ Robinson (Reel Psychiatry:Movie Portrayals of Psychiatric Conditions), p. 84-85
  95. ^ ER: The Complete Seventh Season [6 Discs / WS] - Widescreen Subtitle - DVD
  96. ^ ER: Complete Ninth Season (6PC) / (WS DIG) - Widescreen - DVD

Cited texts

  • Goodwin FK, Jamison KR (1990). Manic-Depressive Illness. New York: Oxford University Press. ISBN 0-19-503934-3.

Further reading

Contemporary first-person accounts on this subject include

  • Jamison, Kay Redfield. 1995. An Unquiet Mind: A Memoir of Moods and Madness. New York: Knopf. ISBN 0-330-34651-2.
  • Simon, Lizzie. 2002. Detour: My Bipolar Road Trip in 4-D. New York: Simon and Schuster. ISBN 0-7434-4659-3.
  • Behrman, Andy. 2002. Electroboy: A Memoir of Mania. New York: Random House, 2002. ISBN 0-375-50358-7.
  • Lovelace, David. 2008. Scattershot: My Bipolar Family. New York: Dutton Adult, 2008. ISBN 0-525-95078-8.

For a practical guide to living with bipolar disorder from the perspective of the sufferer, see

For a critique of genetic explanations of bipolar disorder, see

For readings regarding bipolar disorder in children, see:

  • Raeburn, Paul. 2004. Acquainted with the Night: A Parent's Quest to Understand Depression and Bipolar Disorder in His Children.
  • Earley, Pete. Crazy. 2006. New York: G. P. Putnam's Sons. ISBN 0-399-15313-6. A father's account of his son's bipolar disorder.
  • About Pediatric Bipolar Disorder: http://www.bpkids.org/site/PageServer?pagename=lrn_about
  • The Child and Adolescent Bipolar Foundation: http://www.bpkids.org
  • Time Magazine checklist for childhood/adolescent bipolarity: www.time.com/time/covers/1101020819/worksheet/
  • A Model IEP for a bipolar child's medication that works correctly: http://www.bipolarchild.com/iep.html

Classic works on this subject include

  • Kraepelin, Emil. 1921. Manic-depressive Insanity and Paranoia ISBN 0-405-07441-7 (English translation of the original German from the earlier eighth edition of Kraepelin's textbook — now outdated, but a work of major historical importance).
  • Touched With Fire: Manic-Depressive Illness and the Artistic Temperament by Kay Redfield Jamison (The Free Press: Macmillian, Inc., New York, 1993) 1996 reprint: ISBN 0-684-83183-X
  • Mind Over Mood: Cognitive Treatment Therapy Manual for Clients by Christine Padesky, Dennis Greenberger. ISBN 0-89862-128-3

External links